Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.

Sutherland CS, Ademi Z, Michaud J, Schur N, Lingg M, Bhadhuri A, Pache TD, Bitzer J, Suchon P, Albert V, Hersberger KE, Tanackovic G, Schwenkglenks M.

BMJ Open. 2019 Nov 6;9(11):e031325. doi: 10.1136/bmjopen-2019-031325.

2.

OCT Biometry (B-OCT): A New Method for Measuring Ocular Axial Dimensions.

Sikorski BL, Suchon P.

J Ophthalmol. 2019 Aug 14;2019:9192456. doi: 10.1155/2019/9192456. eCollection 2019.

3.

Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.

Venton G, Turcanu M, Colle J, Thuny F, Chebrek S, Farnault L, Mercier C, Ivanov V, Fanciullino R, Suchon P, Jarrot PA, Aissi K, Roche P, Cautela J, Arcani R, Costello R.

Eur J Intern Med. 2019 Oct;68:71-75. doi: 10.1016/j.ejim.2019.08.004. Epub 2019 Aug 14.

PMID:
31421946
4.

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.

Lindström S, Wang L, Smith EN, Gordon W, van Hylckama Vlieg A, de Andrade M, Brody JA, Pattee JW, Haessler J, Brumpton BM, Chasman DI, Suchon P, Chen MH, Turman C, Germain M, Wiggins KL, MacDonald J, Braekkan SK, Armasu SM, Pankratz N, Jackson RD, Nielsen JB, Giulianini F, Puurunen MK, Ibrahim M, Heckbert SR, Damrauer SM, Natarajan P, Klarin D; Million Veteran Program, de Vries PS, Sabater-Lleal M, Huffman JE; CHARGE Hemostasis Working Group, Bammler TK, Frazer KA, McCauley BM, Taylor K, Pankow JS, Reiner AP, Gabrielsen ME, Deleuze JF, O'Donnell CJ, Kim J, McKnight B, Kraft P, Hansen JB, Rosendaal FR, Heit JA, Psaty BM, Tang W, Kooperberg C, Hveem K, Ridker PM, Morange PE, Johnson AD, Kabrhel C, Trégouët DA, Smith NL.

Blood. 2019 Nov 7;134(19):1645-1657. doi: 10.1182/blood.2019000435.

PMID:
31420334
5.

Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.

Arcani R, Venton G, Colle J, Suchon P, Ivanov V, Mercier C, Farnault L, Roche P, Lafage M, Brunet C, Azouza W, Pourroy B, Fanciullino R, Costello R.

Eur J Haematol. 2019 Oct;103(4):385-392. doi: 10.1111/ejh.13297. Epub 2019 Aug 7.

PMID:
31319001
6.

Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families.

Suchon P, Resseguier N, Ibrahim M, Robin A, Venton G, Barthet MC, Brunet D, Saut N, Alessi MC, Trégouët DA, Morange PE.

TH Open. 2019 Jan 28;3(1):e28-e35. doi: 10.1055/s-0039-1677807. eCollection 2019 Jan.

7.

Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation.

Ibrahim-Kosta M, Suchon P, Couturaud F, Smadja D, Olaso R, Germain M, Saut N, Goumidi L, Derbois C, Thibord F, Debette S, Amouyel P, Deleuze JF, van Doorn P, Castoldi E, Patin E, Alessi MC, Trégouët DA, Morange PE.

Sci Rep. 2019 Mar 6;9(1):3750. doi: 10.1038/s41598-019-40172-x.

8.

OPTIMIR, a novel algorithm for integrating available genome-wide genotype data into miRNA sequence alignment analysis.

Thibord F, Perret C, Roux M, Suchon P, Germain M, Deleuze JF, Morange PE, Trégouët DA; GENMED Consortium.

RNA. 2019 Jun;25(6):657-668. doi: 10.1261/rna.069708.118. Epub 2019 Feb 28.

9.

Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.

Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, Delgado GE, Guo X, Bartz TM, Martinez-Perez A, Germain M, de Haan HG, Ozel AB, Polasek O, Smith AV, Eicher JD, Reiner AP, Tang W, Davies NM, Stott DJ, Rotter JI, Tofler GH, Boerwinkle E, de Maat MPM, Kleber ME, Welsh P, Brody JA, Chen MH, Vaidya D, Soria JM, Suchon P, van Hylckama Vlieg A, Desch KC, Kolcic I, Joshi PK, Launer LJ, Harris TB, Campbell H, Rudan I, Becker DM, Li JZ, Rivadeneira F, Uitterlinden AG, Hofman A, Franco OH, Cushman M, Psaty BM, Morange PE, McKnight B, Chong MR, Fernandez-Cadenas I, Rosand J, Lindgren A; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC), Gudnason V, Wilson JF, Hayward C, Ginsburg D, Fornage M, Rosendaal FR, Souto JC, Becker LC, Jenny NS, März W, Jukema JW, Dehghan A, Trégouët DA, Morrison AC, Johnson AD, O'Donnell CJ, Strachan DP, Lowenstein CJ, Smith NL.

Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532.

10.

Hematopoietic reconstitution after autologous hematopoietic stem cell transplantation: do CD45 (+) CD34 (+) CD38 (-) progenitors really matter in real life?

Venton G, Suchon P, Colle J, Baier C, Sanderson F, Poullin P, Ivanov V, Mercier C, Farnault L, Roche P, Arcani R, Fanciullino R, Brunet C, Philip PJM, Costello R.

Transfus Apher Sci. 2018 Jun;57(3):406-408. doi: 10.1016/j.transci.2018.04.021. Epub 2018 Apr 24. No abstract available.

PMID:
29709543
11.

Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.

Saultier P, Szepetowski S, Canault M, Falaise C, Poggi M, Suchon P, Barlogis V, Michel G, Loyau S, Jandrot-Perrus M, Bordet JC, Alessi MC, Chambost H.

Haematologica. 2018 Jun;103(6):e264-e267. doi: 10.3324/haematol.2017.186304. Epub 2018 Feb 22. Review. No abstract available.

12.

Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.

Deharo P, Quilici J, Camoin-Jau L, Johnson TW, Bassez C, Bonnet G, Fernandez M, Ibrahim M, Suchon P, Verdier V, Fourcade L, Morange PE, Bonnet JL, Alessi MC, Cuisset T.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2560-2570. doi: 10.1016/j.jcin.2017.08.044.

13.

Risk prediction of developing venous thrombosis in combined oral contraceptive users.

McDaid A, Logette E, Buchillier V, Muriset M, Suchon P, Pache TD, Tanackovic G, Kutalik Z, Michaud J.

PLoS One. 2017 Jul 27;12(7):e0182041. doi: 10.1371/journal.pone.0182041. eCollection 2017.

14.

Vorinostat and Mithramycin A in combination therapy as an interesting strategy for the treatment of Sézary T lymphoma: a transcriptomic approach.

Ragheb R, Venton G, Chelbi R, Bonnet N, Le Treut T, Ivanov V, Mercier C, Poulin P, Beaufils N, Gabert J, Suchon P, Rihet P, Loriod B, Kahn-Perlès B, Costello RT.

Arch Dermatol Res. 2017 Oct;309(8):611-623. doi: 10.1007/s00403-017-1761-0. Epub 2017 Jul 10.

15.

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.

Albaladejo P, Samama CM, Sié P, Kauffmann S, Mémier V, Suchon P, Viallon A, David JS, Gruel Y, Bellamy L, de Maistre E, Romegoux P, Thoret S, Pernod G, Bosson JL; GIHP-NACO Study Group.

Anesthesiology. 2017 Jul;127(1):111-120. doi: 10.1097/ALN.0000000000001631.

PMID:
28410272
16.

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.

Suchon P, Germain M, Delluc A, Smadja D, Jouven X, Gyorgy B, Saut N, Ibrahim M, Deleuze JF, Alessi MC, Morange PE, Trégouët DA.

Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.

17.

Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.

Tripodi A, Chantarangkul V, Cini M, Devreese K, Dlott JS, Giacomello R, Gray E, Legnani C, Martinuzzo ME, Pradella P, Siegemund A, Subramanian S, Suchon P, Testa S.

J Thromb Haemost. 2017 Jun;15(6):1180-1190. doi: 10.1111/jth.13678. Epub 2017 Apr 18.

18.

Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels.

Sennblad B, Basu S, Mazur J, Suchon P, Martinez-Perez A, van Hylckama Vlieg A, Truong V, Li Y, Gådin JR, Tang W, Grossman V, de Haan HG, Handin N, Silveira A, Souto JC, Franco-Cereceda A, Morange PE, Gagnon F, Soria JM, Eriksson P, Hamsten A, Maegdefessel L, Rosendaal FR, Wild P, Folsom AR, Trégouët DA, Sabater-Lleal M.

Hum Mol Genet. 2017 Feb 1;26(3):637-649. doi: 10.1093/hmg/ddw401.

19.

α1 -antitrypsin Pittsburgh and plasmin-mediated proteolysis.

Henneuse A, Suchon P, Chambost H, Morange PE, Frere C, Alessi MC.

J Thromb Haemost. 2016 Oct;14(10):2023-2026. doi: 10.1111/jth.13426. Epub 2016 Sep 2.

20.

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.

Venton G, Pérez-Alea M, Baier C, Fournet G, Quash G, Labiad Y, Martin G, Sanderson F, Poullin P, Suchon P, Farnault L, Nguyen C, Brunet C, Ceylan I, Costello RT.

Blood Cancer J. 2016 Sep 9;6(9):e469. doi: 10.1038/bcj.2016.78.

21.

Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.

Venton G, Labiad Y, Colle J, Fino A, Afridi S, Torres M, Monteuil S, Loriod B, Fernandez-Nunez N, Farnault L, Suchon P, Mattei JC, Rihet P, Bergon A, Nguyen C, Baier C, Costello R.

Immunol Res. 2016 Dec;64(5-6):1225-1236.

PMID:
27481509
22.

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.

Suchon P, Al Frouh F, Ibrahim M, Sarlon G, Venton G, Alessi MC, Trégouët DA, Morange PE.

Clin Genet. 2017 Jan;91(1):131-136. doi: 10.1111/cge.12833. Epub 2016 Aug 22.

PMID:
27414984
23.

Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.

Alessi MC, Gaudin C, Grosjean P, Martin V, Timsit S, Mahagne MH, Larrue V, Sibon I, Zuber M, Brouns R, Montaner J, Castellanos M, Donazzolo Y, Cho TH, Suissa L, Mechtouff L, Derex L, Suchon P, Mezzapesa A, Nighoghossian N.

Cerebrovasc Dis. 2016;42(5-6):404-414. Epub 2016 Jul 8.

PMID:
27387478
24.

Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.

Venton G, Adam H, Colle J, Labiad Y, Mercier C, Ivanov V, Suchon P, Fanciullino R, Farnault L, Costello R.

Med Mal Infect. 2016 Jun;46(4):226-9. doi: 10.1016/j.medmal.2016.03.008. Epub 2016 Apr 25.

PMID:
27126350
25.

PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency.

Alhenc-Gelas M, Plu-Bureau G, Horellou MH, Rauch A, Suchon P; GEHT genetic thrombophilia group.

Thromb Haemost. 2016 Mar;115(3):570-9. doi: 10.1160/TH15-05-0391. Epub 2015 Oct 15.

PMID:
26466767
26.

Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study.

Montoya J, Matta NB, Suchon P, Guzian MC, Lambert NC, Mattei JP, Guis S, Breban M, Roudier J, Balandraud N.

Ann Rheum Dis. 2016 May;75(5):879-82. doi: 10.1136/annrheumdis-2015-208187. Epub 2015 Oct 12.

PMID:
26458738
27.

Genetics of Venous Thrombosis: update in 2015.

Morange PE, Suchon P, Trégouët DA.

Thromb Haemost. 2015 Nov;114(5):910-9. doi: 10.1160/TH15-05-0410. Epub 2015 Sep 10. Review.

PMID:
26354877
28.

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.

Suchon P, Al Frouh F, Henneuse A, Ibrahim M, Brunet D, Barthet MC, Aillaud MF, Venton G, Alessi MC, Trégouët DA, Morange PE.

Thromb Haemost. 2016 Jan;115(1):135-42. doi: 10.1160/TH15-01-0045. Epub 2015 Aug 20.

PMID:
26290123
29.

Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report.

Venton G, Colle J, Mercier C, Fanciullino R, Ciccolini J, Ivanov V, Suchon P, Sebahoun G, Beaufils N, Gabert J, Hadjaj D, Costello R.

Pharmacogenomics. 2015;16(7):677-9. doi: 10.2217/pgs.15.25. Epub 2015 May 7.

PMID:
25950190
30.

Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.

Germain M, Chasman DI, de Haan H, Tang W, Lindström S, Weng LC, de Andrade M, de Visser MC, Wiggins KL, Suchon P, Saut N, Smadja DM, Le Gal G, van Hylckama Vlieg A, Di Narzo A, Hao K, Nelson CP, Rocanin-Arjo A, Folkersen L, Monajemi R, Rose LM, Brody JA, Slagboom E, Aïssi D, Gagnon F, Deleuze JF, Deloukas P, Tzourio C, Dartigues JF, Berr C, Taylor KD, Civelek M, Eriksson P; Cardiogenics Consortium, Psaty BM, Houwing-Duitermaat J, Goodall AH, Cambien F, Kraft P, Amouyel P, Samani NJ, Basu S, Ridker PM, Rosendaal FR, Kabrhel C, Folsom AR, Heit J, Reitsma PH, Trégouët DA, Smith NL, Morange PE.

Am J Hum Genet. 2015 Apr 2;96(4):532-42. doi: 10.1016/j.ajhg.2015.01.019. Epub 2015 Mar 12.

31.

Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.

Rubio-Terrés C, Soria JM, Morange PE, Souto JC, Suchon P, Mateo J, Saut N, Rubio-Rodríguez D, Sala J, Gracia A, Pich S, Salas E.

Appl Health Econ Health Policy. 2015 Apr;13(2):233-42. doi: 10.1007/s40258-015-0153-x.

32.

Thrombin generation potential and whole-blood DNA methylation.

Rocañín-Arjó A, Dennis J, Suchon P, Aïssi D, Truong V, Trégouët DA, Gagnon F, Morange PE.

Thromb Res. 2015 Mar;135(3):561-4. doi: 10.1016/j.thromres.2014.12.010. Epub 2014 Dec 12. No abstract available.

PMID:
25563678
33.

Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism.

Rubio-Terrés C, Soria JM, Morange PE, Suchon P, Souto JC, Mateo J, Saut N, Rubio-Rodríguez D, Sala J, Gracia A, Pich S, Salas E.

Value Health. 2014 Nov;17(7):A488. doi: 10.1016/j.jval.2014.08.1437. Epub 2014 Oct 26. No abstract available.

34.

Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.

Leroux D, Hezard N, Lebreton A, Bauters A, Suchon P, de Maistre E, Biron C, Huisse MG, Ternisien C, Voisin S, Gruel Y, Pouplard C.

Br J Haematol. 2014 Sep;166(5):774-82. doi: 10.1111/bjh.12939. Epub 2014 May 12.

PMID:
24815503
35.

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model.

Cohen W, Castelli C, Suchon P, Bouvet S, Aillaud MF, Brunet D, Barthet MC, Alessi MC, Trégouët DA, Morange PE.

J Thromb Haemost. 2014 Feb;12(2):138-46.

PMID:
24738120
36.

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model.

Cohen W, Castelli C, Suchon P, Bouvet S, Aillaud MF, Brunet D, Barthet MC, Alessi MC, Trégouët DA, Morange PE.

J Thromb Haemost. 2014 Feb;12(2):138-146. doi: 10.1111/jth.12461.

37.

Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory.

Cassagne C, Cella AL, Suchon P, Normand AC, Ranque S, Piarroux R.

Med Mycol. 2013 May;51(4):371-7. doi: 10.3109/13693786.2012.720720. Epub 2012 Sep 16.

PMID:
22978312
38.

[Polymorphism rs9939609 of FTO gene is related to the body mass index in children from Podlaskie voievodship].

Tercjak-Rećko M, Luczyński W, Bernatowicz P, Zalewski G, Rembińska M, Lachowska U, Rećko P, Suchoń P, Czaban M, Sokal J, Kopalińska A, Pajer Z, Bogdanowicz K, Nikliński J, Bossowski A.

Med Wieku Rozwoj. 2012 Jan-Mar;16(1):53-60. Polish.

39.

[Overweight, obesity and metabolic syndrome in children with type 1 diabetes melllitus].

Luczyński W, Szypowska A, Bossowski A, Ramotowska A, Rećko P, Rembińska M, Tercjak M, Blecharczyk B, Lachowska U, Suchoń P, Wiśniewska K, Bernatowicz P, Głowińska-Olszewska B.

Pediatr Endocrinol Diabetes Metab. 2010;16(2):83-8. Polish.

PMID:
20813084

Supplemental Content

Loading ...
Support Center